Fig. 4

Overexpressing BCL2L11 abates sh-PVT1-mediated effects on 16HBE cell apoptosis and inflammation under CSE treatment. A-B RT-qPCR and western blotting for determining BCL2L11 overexpression efficiency. C CCK-8 for evaluating the viability of 16HBE cells with indicated treatments. D, E Flow cytometry for measuring cell apoptosis. F Western blotting for detecting apoptosis-related proteins. G, H ELISA for examining concentrations of IFN-γ and TNF-α. **p<0.01, ***p<0.001 vs. sh-NC group; ##p<0.01 vs. sh-PVT1 + vector group